Last week’s headlines included the new research collaboration between Novonesis and Novo Nordisk, why Yerba Maté could be the next breakout star for the weight management category and GNC expanding its partnership Watsons in Singapore. Novonesis and Novo Nordisk are joining forces in a new research collaboration to explore solutions that seek to preserve and optimize metabolic health and well-being. Yerba Maté, the traditional South American tea, is gaining serious traction—especially online, where it is been being highlighted for its potential weight loss benefits. According to Signals data, consumer interest in Yerba Maté surged in 2025, with search volume increasing 40% between January and June. A systematic review of 32 studies found Yerba Maté improves metabolism and has antioxidant and anti-inflammatory effects, Ghannoum noted.